Marjolin's ulcer. The LSU experience.

Abstract:

:Skin cancers originating in areas of chronic injury (Marjolin's ulcers) are thought to behave in a more aggressive fashion than those due to other causes. The initial surgical treatment, especially the management of the regional lymph nodes, remains controversial. This review of 37 patients with Marjolin's ulcer evaluated the effectiveness of local surgical treatment at our center. Three of 18 patients treated with amputation developed recurrences and died of metastatic disease. Five of 16 patients treated by wide excision developed recurrences, two dying with metastatic disease, the remaining three apparently cured by additional surgery. Only six (17.6%) of the patients treated by "local" modalities, i.e., wide excision or amputation, developed subsequent regional node metastases. Recurrences following local excision tend to be local and can usually be managed by re-excision or amputation. It can be inferred from this study that prophylactic node dissections are not required in most patients with Marjolin's ulcers.

journal_name

Cancer

journal_title

Cancer

authors

Barr LH,Menard JW

doi

10.1002/1097-0142(19830701)52:1<173::aid-cncr28205

subject

Has Abstract

pub_date

1983-07-01 00:00:00

pages

173-5

issue

1

eissn

0008-543X

issn

1097-0142

journal_volume

52

pub_type

杂志文章

相关文献

CANCER文献大全
  • Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.

    abstract:BACKGROUND:Management of unresectable colorectal liver metastases (CLM) can be by regional (hepatic arterial infusion [HAI]) or systemic chemotherapy, or by symptom control alone. In this study the costs of each type of management were related to clinical outcome in 134 patients with CLM. METHODS:The costs (both in te...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Durand-Zaleski I,Earlam S,Fordy C,Davies M,Allen-Mersh TG

    更新日期:1998-09-01 00:00:00

  • Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.

    abstract:BACKGROUND:Fas (CD95/APO-1) and Fas ligand (FasL) play key roles in immunologic homeostasis and immune privilege and may regulate normal cell turnover. Earlier studies had suggested that FasL-positive pancreatic carcinoma cell lines can induce apoptosis in T cells, thereby evading host immune surveillance. In the curre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10549

    authors: Bernstorff WV,Glickman JN,Odze RD,Farraye FA,Joo HG,Goedegebuure PS,Eberlein TJ

    更新日期:2002-05-15 00:00:00

  • Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.

    abstract:BACKGROUND:Chemotherapy intensification may lead to new forms of toxicity such as hemolytic uremic syndrome. METHODS:Three patients are described who developed this complication 4 to 6 months after high dose chemotherapy followed by autologous stem cell support. The literature on this subject is reviewed. RESULTS:One...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19951201)76:11<2338::aid-cncr282

    authors: van der Lelie H,Baars JW,Rodenhuis S,van Dijk MA,de Glas-Vos CW,Thomas BL,van Oers RH,von dem Borne AE

    更新日期:1995-12-01 00:00:00

  • Religion, spirituality, and health outcomes in cancer: A case for a meta-analytic investigation.

    abstract::A growing body of research shows that a majority of patients with cancer report having religious and spiritual (R/S) beliefs, engaging in R/S behaviors, or deriving comfort from R/S experiences. These studies have been reviewed but not subjected to rigorous critical analysis. A meta-analytic approach is needed to prov...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.29349

    authors: Salsman JM,Fitchett G,Merluzzi TV,Sherman AC,Park CL

    更新日期:2015-11-01 00:00:00

  • ESR1 mutations in breast cancer.

    abstract::The acquisition of ligand-independent ESR1 mutations during aromatase inhibitor therapy in metastatic estrogen receptor (ER)-positive breast cancer is a common mechanism of hormonal therapy resistance. Preclinical and clinical studies have demonstrated that ESR1 mutations can preexist in primary tumors and can be enri...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.32345

    authors: Dustin D,Gu G,Fuqua SAW

    更新日期:2019-11-01 00:00:00

  • Radioimmunoassay for plasma glutathione S-transferase-pi and its clinical application in gastrointestinal cancer.

    abstract:BACKGROUND:Plasma acidic glutathione S-transferase (GST-pi) concentrations in 135 patients with gastrointestinal cancer were measured by an improved radioimmunoassay (RIA). METHODS:Blood was collected into a silicified glass tube containing a specific anticoagulant. The plasma, which was separated rapidly by centrifug...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19951015)76:8<1363::aid-cncr2820

    authors: Fan KC,Huang YC,Li CH

    更新日期:1995-10-15 00:00:00

  • Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.

    abstract:BACKGROUND:Melanoma is the most lethal form of skin cancer, with an estimated 68,130 new cases and 8700 deaths in the United States in 2010. The increasing incidence and high death rate associated with metastatic disease support the need to focus on prevention. The authors used data from the Women's Health Initiative (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27497

    authors: Jagtap D,Rosenberg CA,Martin LW,Pettinger M,Khandekar J,Lane D,Ockene I,Simon MS

    更新日期:2012-10-15 00:00:00

  • Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases.

    abstract::Forty-two cases of sarcomatoid renal cell carcinoma were reviewed clinicopathologically. Twenty-four patients were men, and 18 women; average age was 56.2 years (range, 30-81 years). Eight, 9, 13, and 12 cases were Stages I, II, III, and IV, respectively. Three morphologic patterns of sarcomatoid components were ident...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870201)59:3<516::aid-cncr28205

    authors: Ro JY,Ayala AG,Sella A,Samuels ML,Swanson DA

    更新日期:1987-02-01 00:00:00

  • Government support of cancer research and cancer care health benefits.

    abstract::As the federal government struggles to meet ever-growing budgetary constraints, the need for research into the causes of and potential therapies for treating cancer demands the urgent attention of Congressional leaders. This will require innovative, cost-effective approaches to address the unique needs of cancer resea...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931101)72:9+<2859::aid-cncr282

    authors: Mack C

    更新日期:1993-11-01 00:00:00

  • Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.

    abstract:BACKGROUND:The optimal use of radiation therapy for cancer treatment is hampered by the application of tolerance limits of normal tissues derived empirically from population averages. Such limits do not reflect the considerable differences from patient to patient in susceptibility to late radiation sequelae. Assays tha...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(SICI)1097-0142(19960601)77:11<2379::AID-C

    authors: Peters LJ

    更新日期:1996-06-01 00:00:00

  • Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors.

    abstract::A prospective study was performed on 84 patients with neuroendocrine pancreatic tumors. Fifty-nine (70%) had malignant tumors and received causal medical treatment. Streptozotocin in combination with 5-fluorouracil or doxorubicin was used as first-line treatment and produced overall objective responses in 20 of 44 (45...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900501)65:9<1883::aid-cncr2820

    authors: Eriksson B,Skogseid B,Lundqvist G,Wide L,Wilander E,Oberg K

    更新日期:1990-05-01 00:00:00

  • Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine.

    abstract:BACKGROUND:This Phase III trial was performed to compare the roles of oral etoposide and intravenous (i.v.) vinblastine in the treatment of Mediterranean Kaposi's Sarcoma (MEKS) in elderly patients with severe disease (Stages II, Ac/B, III, and IV). PATIENTS AND METHODS:Sixty-five patients were randomized to receive e...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19941115)74:10<2873::aid-cncr282

    authors: Brambilla L,Labianca R,Boneschi V,Fossati S,Dallavalle G,Finzi AF,Luporini G

    更新日期:1994-11-15 00:00:00

  • Pulmonary lymphangiomyomatosis: three new cases studied with electron microscopy.

    abstract::Three cases of pulmonary lymphangiomyomatosis are described, with emphasis on the ultrastructural changes. The clinicopathologic features corresponded to those previously described. Each patient was a female in the reproductive years; breathlessness and recurrent pneumothoraces were the predominant clinical features. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197612)38:6<2357::aid-cncr282038

    authors: Basset F,Soler P,Marsac J,Corrin B

    更新日期:1976-12-01 00:00:00

  • Immunotherapy of metastatic renal cell carcinoma.

    abstract::Renal cell carcinoma (RCC) evokes an immune response, which occasionally has resulted in spontaneous and dramatic remissions. In an attempt to reproduce or accentuate this response, various immunotherapeutic strategies have been studied. The most consistent antitumor activity has been reported with interferon-alpha (I...

    journal_title:Cancer

    pub_type: 杂志文章,收录出版,评审

    doi:10.1002/cncr.24236

    authors: McDermott DF

    更新日期:2009-05-15 00:00:00

  • The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist.

    abstract:BACKGROUND:Chemotherapy improves survival for patients with stage III colon cancer, but some older patients with lymph node-positive colon cancer do not see a medical oncologist and, thus, do not receive adjuvant chemotherapy. METHODS:To evaluate the role of the surgeon in determining referrals to medical oncology amo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22462

    authors: Luo R,Giordano SH,Zhang DD,Freeman J,Goodwin JS

    更新日期:2007-03-01 00:00:00

  • Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.

    abstract:BACKGROUND:Preclinical and clinical studies suggest synergistic activity between somatostatin analogues and mammalian target of rapamycin inhibitors. The activity and safety of everolimus was assessed in combination with octreotide long-acting repeatable (LAR) in patients with neuroendocrine tumors (NETs) of gastroente...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.28726

    authors: Bajetta E,Catena L,Fazio N,Pusceddu S,Biondani P,Blanco G,Ricci S,Aieta M,Pucci F,Valente M,Bianco N,Mauri CM,Spada F

    更新日期:2014-08-15 00:00:00

  • Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma.

    abstract:BACKGROUND:Several of the large studies addressing prognosis and survival from hepatocellular carcinoma (HCC) have been from Europe and Asia, but only a few have emanated from North America. Survival statistics from other parts of the world may not be applicable to the North American population because of etiologic, de...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950815)76:4<579::aid-cncr28207

    authors: Nzeako UC,Goodman ZD,Ishak KG

    更新日期:1995-08-15 00:00:00

  • Prognostic factors for lymphedema after primary treatment of breast carcinoma.

    abstract:BACKGROUND:Lymphedema of the arm is a serious consequence of breast carcinoma treatment. Postmastectomy lymphedema of the upper limb usually is related to certain risk factors such as axillary surgery, radiotherapy, obesity, venous outflow obstruction, delayed wound healing, and infection. The objective of the current ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011001)92:7<1783::aid-cncr1694

    authors: Herd-Smith A,Russo A,Muraca MG,Del Turco MR,Cardona G

    更新日期:2001-10-01 00:00:00

  • Estrogen receptors in male breast cancer: clinical and pathologic correlations.

    abstract::Breast cancer tissue from 12 male patients was evaluated for the presence of estrogen receptors (ER), and at least 10 of 12 were found to be high in ER (ER+). A combination of previously published cases and our own experience indicates that 80% of patients (37/47) have ER+ tumors. This incidence of ER positivity in me...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810101)47:1<134::aid-cncr28204

    authors: Friedman MA,Hoffman PG Jr,Dandolos EM,Lagios MD,Johnston WH,Siiteri PK

    更新日期:1981-01-01 00:00:00

  • The significance of bone and cartilage formation in malignant fibrous histiocytoma of soft tissue.

    abstract::Malignant fibrous histiocytoma of soft tissues (MFH), a mesenchymal tumor of varied morphologic patterns and cell types, sometimes contains bone and cartilage. Such bony and cartilaginous elements in a pleomorphic MFH may pose a difficult diagnostic challenge. An MFH with bone and cartilage can be distinguished from e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820201)49:3<480::aid-cncr28204

    authors: Bhagavan BS,Dorfman HD

    更新日期:1982-02-01 00:00:00

  • The impact of breast reconstruction on the delivery of chemotherapy.

    abstract:BACKGROUND:: The purpose of this study was to evaluate the impact of postmastectomy breast reconstruction on the timing of chemotherapy. METHODS:: The authors included stage I-III breast cancer patients from 8 National Comprehensive Cancer Network institutions for whom guidelines recommended chemotherapy. Surgery type...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24891

    authors: Alderman AK,Collins ED,Schott A,Hughes ME,Ottesen RA,Theriault RL,Wong YN,Weeks JC,Niland JC,Edge SB

    更新日期:2010-04-01 00:00:00

  • Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study.

    abstract:BACKGROUND:Irinotecan-based chemotherapy regimens are 1 option for treatment of metastatic colorectal cancer (mCRC). The authors report the safety and efficacy of such regimens in elderly patients using a large phase III trial (bolus, infusional, or capecitabine with camptostar-celecoxib [BICC-C]) cohort. METHODS:In p...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/cncr.24305

    authors: Jackson NA,Barrueco J,Soufi-Mahjoubi R,Marshall J,Mitchell E,Zhang X,Meyerhardt J

    更新日期:2009-06-15 00:00:00

  • Closing the divide: diverse populations and cancer survivorship.

    abstract::Currently, there is a "divide" between cancer survivorship initiatives and minority participation. The level of participation is nearly nonexistent in many cancer support and control initiatives. Cancer survivorship resources that facilitate access to treatment, psychosocial interventions, clinical trials, and researc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21251

    authors: Guidry JJ,Torrence W,Herbelin S

    更新日期:2005-12-01 00:00:00

  • Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.

    abstract:BACKGROUND:Proliferating cell nuclear antigen (PCNA) is an intranuclear protein that is linked closely to the cell cycle. An immunohistochemical study was performed on the expression of PCNA in various sized hepatocellular carcinomas (HCCs) to determine the relation between the proliferative activity of cancer cells an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950801)76:3<399::aid-cncr28207

    authors: Suehiro T,Matsumata T,Itasaka H,Yamamoto K,Kawahara N,Sugimachi K

    更新日期:1995-08-01 00:00:00

  • Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators.

    abstract:BACKGROUND:Radiologic Diagnostic Oncology Group 5 is a multicenter clinical trial designed to evaluate fine-needle aspiration (FNA) of nonpalpable breast lesions performed by multiple operators using the same protocol. METHODS:Four hundred and nineteen women with mammographically detected nonpalpable breast lesions we...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/(sici)1097-0142(19980215)82:4<679::aid-cnc

    authors: Pisano ED,Fajardo LL,Tsimikas J,Sneige N,Frable WJ,Gatsonis CA,Evans WP,Tocino I,McNeil BJ

    更新日期:1998-02-15 00:00:00

  • Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.

    abstract:BACKGROUND:The objective of this Phase II study was to evaluate the concept of sequential chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma (NSCLC) by the administration of carboplatin plus gemcitabine followed by of paclitaxel. METHODS:Patients with Stage IIIB (pleural effusion) or ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20010701)92:1<146::aid-cncr1302>

    authors: Edelman MJ,Gandara DR,Lau DH,Lara P,Lauder IJ,Tracy D

    更新日期:2001-07-01 00:00:00

  • Treatment of fludarabine-refractory chronic lymphocytic leukemia.

    abstract::The development of resistance to purine analogs defines a poor-risk subset of patients with chronic lymphocytic leukemia (CLL). Although in recent years chemoimmunotherapeutic combinations such as fludarabine, cyclophosphamide, and rituximab have induced response rates of 95% in previously untreated patients and incre...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.24329

    authors: Tsimberidou AM,Keating MJ

    更新日期:2009-07-01 00:00:00

  • Significance of a (4;11) translocation in acute lymphoblastic leukemia.

    abstract::This report describes a case of null cell congenital acute lymphoblastic leukemia associated with a (4;11) translocation. This chromosome abnormality is associated with acute lymphoblastic leukemia and probably more specifically with congenital acute lymphoblastic leukemia. A review of the literature is presented. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820801)50:3<503::aid-cncr28205

    authors: Esseltine DW,Vekemans M,Seemayer T,Reece E,Gordon J,Whitehead VM

    更新日期:1982-08-01 00:00:00

  • Lung cancer mortality risk among breast cancer patients treated with anti-estrogens.

    abstract:BACKGROUND:The Women's Health Initiative randomized clinical trial reported that menopausal hormone therapy increases lung cancer mortality risk. If this is true, use of anti-estrogens should be associated with decreased lung cancer mortality risk. The authors compared lung cancer incidence and mortality among breast c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25638

    authors: Bouchardy C,Benhamou S,Schaffar R,Verkooijen HM,Fioretta G,Schubert H,Vinh-Hung V,Soria JC,Vlastos G,Rapiti E

    更新日期:2011-03-15 00:00:00

  • Costs of cancer along the care continuum: What we can expect based on recent literature.

    abstract:BACKGROUND:Cancer costs should be discussed by patients and providers, but information is not readily available. Results from recently published studies (in the last 5 years) on direct and indirect cancer costs may help guide these discussions. METHODS:The authors reviewed studies published between 2013 and 2017 that ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.31643

    authors: Pisu M,Henrikson NB,Banegas MP,Yabroff KR

    更新日期:2018-11-01 00:00:00